Eric Michael Robinson
Impact in
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Cutaneous Melanoma Detection and Management 4
-
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Ilkka Ilonen (8 shared papers)Iman Osman (6 shared papers)David Polsky (5 shared papers)Anna C. Pavlick (3 shared papers)Jari Veli Räsänen (5 shared papers)Richard L. Shapiro (5 shared papers)Yongzhao Shao (3 shared papers)Manohar R. Furtado (1 shared paper)
- Journals
- Clinical Lung Cancer (2 papers)Oncology (2 papers)Journal of Surgical Oncology (1 paper)The American Journal of Cardiology (1 paper)JAMA Otolaryngology–Head & Neck Surgery (1 paper)
- Partner nations
- United StatesFinlandCanada
In The Last Decade
Eric Michael Robinson
19 papers receiving 708 citations
Eric Michael Robinson's Hit Papers
Peers
Comparison fields: 5 of 51
- Cell Biology 239
- Cancer Research 76
- Oncology 126
- Pulmonary and Respiratory Medicine 122
- Molecular Biology 167
Countries citing papers authored by Eric Michael Robinson
This map shows the geographic impact of Eric Michael Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Michael Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Michael Robinson more than expected).
Fields of papers citing papers by Eric Michael Robinson
This network shows the impact of papers produced by Eric Michael Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Michael Robinson. The network helps show where Eric Michael Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Michael Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Hit paper breakdown → | 2015 | 468 |
| 2 | 2015 | 62 | |
| 3 | 2015 | 33 | |
| 4 | 2019 | 25 | |
| 5 | 2022 | 17 | |
| 6 | 2020 | 15 | |
| 7 | 2019 | 14 | |
| 8 | 2016 | 13 | |
| 9 | 2021 | 13 | |
| 10 | 2018 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2017 | 6 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2017 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2023 | 0 |
About Eric Michael Robinson
Eric Michael Robinson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Cancer Research and Molecular Biology, having authored 20 papers that have together received 715 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers), Gastroesophageal reflux and treatments (1 paper), Healthcare Policy and Management (1 paper), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper) and Cardiac Valve Diseases and Treatments (1 paper). The work is most often cited by research in Cell Biology (239 citations), Cancer Research (76 citations), Oncology (126 citations), Pulmonary and Respiratory Medicine (122 citations) and Molecular Biology (167 citations). Eric Michael Robinson has collaborated with scholars based in United States, Finland and Canada. Frequent co-authors include Ilkka Ilonen, Iman Osman, David Polsky, Anna C. Pavlick, Jari Veli Räsänen, Richard L. Shapiro, Yongzhao Shao, Manohar R. Furtado, Sarah Ann Weiss and Yilong Zhang. Their work appears in journals such as Clinical Lung Cancer, Oncology, Journal of Surgical Oncology, The American Journal of Cardiology and JAMA Otolaryngology–Head & Neck Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.